Patient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1477-7525
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Patient-reported outcomes in meta-analyses – Part 1: assessing risk of bias and combining outcomes ; volume:11 ; number:1 ; day:1 ; month:7 ; year:2013 ; pages:1-10 ; date:12.2013
Health and quality of life outcomes ; 11, Heft 1 (1.7.2013), 1-10, 12.2013
- Urheber
-
Johnston, Bradley C.
Patrick, Donald L.
Busse, Jason W.
Schünemann, Holger J.
Agarwal, Arnav
Guyatt, Gordon
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/1477-7525-11-109
- URN
-
urn:nbn:de:101:1-2019101700544252179940
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:37 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Johnston, Bradley C.
- Patrick, Donald L.
- Busse, Jason W.
- Schünemann, Holger J.
- Agarwal, Arnav
- Guyatt, Gordon
- SpringerLink (Online service)
Ähnliche Objekte (12)
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes
Improving the use of research evidence in guideline development: 14. Reporting guidelines
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes
Improving the use of research evidence in guideline development: 14. Reporting guidelines
Der Kohlendioxidtransport im Organismus : Untersuchungen zur Kinetik des pulmonalen CO2-Austauschs und zum Einfluss des Laktats auf das oxylabile CO2
Improving the use of research evidence in guideline development: 6. Determining which outcomes are important
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of intermediate-intensity anticoagulation in critically ill patients
Reviews: Rapid! Rapid! Rapid! …and systematic
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: January 2022 update on the use of therapeutic-intensity anticoagulation in acutely ill patients
Using patient values and preferences to inform the importance of health outcomes in practice guideline development following the GRADE approach
Developing clinical practice guidelines: types of evidence and outcomes; values and economics, synthesis, grading, and presentation and deriving recommendations
Improving the use of research evidence in guideline development: 12. Incorporating considerations of equity
Improving the use of research evidence in guideline development: 16. Evaluation
American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis for patients with COVID-19 : : March 2022 update on the use of anticoagulation in critically ill patients
Improving the use of research evidence in guideline development: 5. Group processes